Objective: To assess if speech perception improves after the upgrade from the TEMPO+ to the OPUS 2 processor. Method: In this retrospective study, 45 subjects (54 ears) implanted with a cochlear implant were upgraded from the TEMPO+ (continuous interleaved sampling + coding strategy) to the OPUS 2 processor (fine structure processing). Before the upgrade, patients were tested with the Freiburg monosyllable (FM) and the Hochmair-Schulz-Moser (HSM) sentence test in quiet and in noise. Four weeks after the upgrade, subjects were again assessed with the same tests. Results: In quiet, mean FM results improved from 62.0% (±21.3%) to 77.8% (±15.2%) and HSM sentences from 69.9% (±26.1%) to 77.9% (±22.1%). In noise, mean FM results improved from 27.3% (±17.1%) to 52.1% (±18.6%) and HSM sentences from 40.4% (±29.1%) to 58.0% (±26.1%). The upgrade to the OPUS 2 was statistically very significant for all speech perception tests (p < 0.001). Additionally, subjects stated that the OPUS 2 initially sounded ‘awkward’ but that quality and speech perception improved after a certain adaptation time. Conclusion: Speech understanding in quiet and noise significantly improved with the OPUS 2 in all speech perception tests.

Keywords:
Speech perception, TEMPO+, OPUS 2, Audio processor upgrade, Fine structure processing
This content is only available via PDF.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.